Patents Assigned to The Johns Hopkins School of Medicine
  • Patent number: 7647120
    Abstract: A system for treating patients affected both by hearing loss and by balance disorders related to vestibular hypofunction and/or malfunction, which includes sensors of sound and head movement, processing circuitry, a power source, and an implantable electrical stimulator capable of stimulating areas of the cochlea and areas of the vestibular system.
    Type: Grant
    Filed: May 4, 2007
    Date of Patent: January 12, 2010
    Assignees: John Hopkins School of Medicine, Advanced Bionics, LLC
    Inventors: Charles C. Della Santina, Michael A. Faltys
  • Patent number: 7303770
    Abstract: Vegetable sources of cancer chemoprotective agents have been identified which are extraordinarily rich in glucosinolates, metabolic precursors of isothiocyanates. The vegetable sources are used to provide a dietary means of reducing the level of carcinogens in mammals.
    Type: Grant
    Filed: April 5, 2001
    Date of Patent: December 4, 2007
    Assignee: Johns Hopkins School of Medicine
    Inventors: Jed W. Fahey, Paul Talalay
  • Patent number: 7225028
    Abstract: A system for treating patients affected both by hearing loss and by balance disorders related to vestibular hypofunction and/or malfunction, which includes sensors of sound and head movement, processing circuitry, a power source, and an implantable electrical stimulator capable of stimulating areas of the cochlea and areas of the vestibular system.
    Type: Grant
    Filed: May 20, 2005
    Date of Patent: May 29, 2007
    Assignees: Advanced Bionics Corporation, Johns Hopkins School of Medicine
    Inventors: Charles C Della Santina, Michael A Faltys
  • Publication number: 20040171567
    Abstract: Methylation of p16 DNA and a resultant decrease in p16 gene expression is associated with transcriptional block and is associated with a variety of neoplasms. A method for detecting a neoplasm in a subject by doming methylation of 5′CpG islands in p16 DNA, or detecting p16 mRNA or polypeptide levels in a sample is also provided.
    Type: Application
    Filed: September 9, 2003
    Publication date: September 2, 2004
    Applicant: THE JOHNS HOPKINS SCHOOL OF MEDICINE
    Inventors: David Sidransky, Stephen B. Baylin
  • Publication number: 20040016032
    Abstract: A method for producing crucifer germplasm, in particular broccoli and cauliflower germplasm, with high levels of cancer chemoprotectant agents which comprises screening a population of plants for glucosinolate profiles and selecting an individual plant with an enhanced alkyl/indole glucosinolate ratio. Subsequent breeding with a selected plant results in varieties, lines, and plants with desirable glucosinolate profiles.
    Type: Application
    Filed: February 14, 2003
    Publication date: January 22, 2004
    Applicant: JOHNS HOPKINS SCHOOL OF MEDICINE
    Inventor: Jed W. Fahey
  • Patent number: 6521818
    Abstract: A method for producing crucifer germplasm, in particular broccoli and cauliflower germplasm, with high levels of cancer chemoprotectant agents is provided which comprises screening a population of plants for glucosinolate profiles and selecting an individual plant with an enhanced alkyl/indole glucosinolate ratio. Subsequent breeding with a selected plant results in varieties, lines, and plants with desirable glucosinolate profiles. A method of growing crucifer sprouts to enhance chemoprotectant activity of the sprouts by germinating the seeds in a limited water volume is also provided. A method for producing crucifer germplasm which produces seeds with reduced leakage of seed material is provided which comprises screening a population of plants for production of seeds with reduced leakage and selecting an individual plant which produces such seeds.
    Type: Grant
    Filed: June 30, 1999
    Date of Patent: February 18, 2003
    Assignee: John Hopkins School of Medicine
    Inventor: Jed W. Fahey
  • Patent number: 6242018
    Abstract: Vegetable sources of cancer chemoprotective agents have been identified which are extraordinarily rich in glucosinolates, metabolic precursors of isothiocyanates. The vegetable sources are used to provide a dietary means of reducing the level of carcinogens in mammals.
    Type: Grant
    Filed: October 25, 1999
    Date of Patent: June 5, 2001
    Assignee: Johns Hopkins School of Medicine
    Inventors: Jed W. Fahey, Paul Talalay
  • Patent number: 6177122
    Abstract: Vegetable sources of cancer chemoprotective agents have been identified which are extraordinarily rich in glucosinolates, metabolic precursors of isothiocyanates. The vegetable sources are used to provide a dietary means of reducing the level of carcinogens in mammals.
    Type: Grant
    Filed: July 20, 1998
    Date of Patent: January 23, 2001
    Assignee: Johns Hopkins School of Medicine
    Inventors: Jed W. Fahey, Paul Talalay
  • Patent number: 6162632
    Abstract: A DNA sequence encoding a transport protein responsible for the physical movement of oxalate and formate across the plasma membrane is provided. The protein, OxlT, can be isolated from the gram negative anaerobe, Oxalobacter formigenes. The protein is part of the three protein oxalate/formate antiport exchange system that allows for conversion of extracellular oxalate to formate+CO.sub.2.The OxlT coding sequence can be used to provide a metabolic energy system to the cell. The system comprises the OxlT transport protein in combination with oxalylCoA decarboxylase and formyl-CoA transferase. Expression cassettes can be designed to express all or part of the system in a target host. Such energy generating systems can be used in industrial settings that utilize fermentation. The energy generating systems of the invention extend culture longevity and increase product yield.
    Type: Grant
    Filed: February 25, 1998
    Date of Patent: December 19, 2000
    Assignee: Johns Hopkins School of Medicine
    Inventors: Peter C. Maloney, Keietsu Abe, Zhong-Shi Ruan
  • Patent number: 6090622
    Abstract: Primordial germ cells extracted from post blastocyst human embryos, such as from the gonadal ridges of a 8-11 week LMP human embryo, are disclosed. The primordial germ cells are cultured in long term culture (more than 30 days) resulting in cells that resemble embryonic stem cells in morphology and pluripotency. The cells are maintained several months in culture and can be genetically manipulated using transgenic technology to insert heterologous genetic material.
    Type: Grant
    Filed: March 31, 1997
    Date of Patent: July 18, 2000
    Assignee: The Johns Hopkins School of Medicine
    Inventors: John D. Gearhart, Michael Joseph Shamblott
  • Patent number: 5968505
    Abstract: Vegetable sources of cancer chemoprotective agents have been identified which are extraordinarily rich in glucosinolates, metabolic precursors of isothiocyanates. The vegetable sources are used to provide a dietary means of reducing the level of carcinogens in mammals.
    Type: Grant
    Filed: December 24, 1997
    Date of Patent: October 19, 1999
    Assignee: Johns Hopkins School of Medicine
    Inventors: Jed W. Fahey, Paul Talalay
  • Patent number: 5968567
    Abstract: Vegetable sources of cancer chemoprotective agents have been identified which are extraordinarily rich in glucosinolates, metabolic precursors of isothiocyanates. The vegetable sources are used to provide a dietary source for reducing the level of carcinogens in mammals.
    Type: Grant
    Filed: April 11, 1997
    Date of Patent: October 19, 1999
    Assignee: John Hopkins School of Medicine
    Inventors: Jed W. Fahey, Paul Talalay
  • Patent number: 5725895
    Abstract: A method of preparing a food product rich in glucosinolates wherein cruciferous seeds, with the exception of cabbage, cress, mustard and radish seeds, are germinated, and sprouts are harvested prior to the 2-leaf stage, to form a food product containing a plurality of sprouts.
    Type: Grant
    Filed: September 15, 1995
    Date of Patent: March 10, 1998
    Assignee: Johns Hopkins School of Medicine
    Inventors: Jed W. Fahey, Paul Talalay